Search Results - haiyan+sun

4 Results

Sort By:

Monoclonal Antibodies Against SARS-CoV-2 Variants

Although the world has returned to a state of relative normalcy, SARS-CoV-2 infections continue to persist worldwide, and immune evasive variants continue to emerge. Monoclonal antibodies (mAbs) are often first in line therapy for SARS-CoV-2 infections, but most have lost utility against the Omicron variant and its subvariants. One mAb cocktail, Evusheld,...

Published: 8/7/2023 | Inventor(s): Qiang Chen, Haiyan Sun, Collin Jugler

Keywords(s):

Category(s): Coronavirus, COVID-19, Life Science (All LS Techs), Protein/Pharma Production in Plants, SARS-CoV-2, Non-Cancer Therapeutics

Method for Producing Self-Replicating, Nucleic Acid-Loaded Virus-Like Particles

Vaccines are an essential tool in preventing and controlling many diseases. Most approved vaccines are inactivated or live attenuated type, however, alternative platforms like mRNA and virus-like particles (VLPs) are being increasingly explored and approved because they generate potent immune responses with great safety profiles. VLPs are particularly...

Published: 2/23/2023 | Inventor(s): Qiang Chen, Haiyan Sun, Collin Jugler, Huafang Lai

Keywords(s):

Category(s): Coronavirus, COVID-19, SARS-CoV-2, Vaccines/Antimicrobials, Pharmaceuticals, Life Science (All LS Techs), Genomic Assays/Reagents/Tools

Cost-Effective Single-Step Process for the Catalytic Conversion of Methane to Methanol/Formaldehyde

Unmet Need: Currently there is no technology available in the market capable of producing Dimethyl Ether (DME) from methane in a single reactor. DME is an attractive substitute for diesel due to its high cetane number, which is a measure of its ignitibility in compression ignition engines. In addition, DME’s quiet combustion and inability to form...

Published: 10/8/2024 | Inventor(s): Su Ha, M Norton, Oscar Marin Flores

Keywords(s):

Category(s): Technologies > Health & Well-being > Chemistry, Technologies > Energy & Environment > Energy

Plant-Produced mAbs Against Chikungunya Virus

Chikungunya virus (CHIKV) is a mosquito‐borne alphavirus, characterized by fever and severe joint pain. The joint pain is often debilitating and can vary in duration, sometimes lasting for years. There are currently no vaccines or therapeutic treatments for CHIKV, instead symptom relief is the primary focus with administration of bed rest, antipyretics/analgesics...

Published: 2/23/2023 | Inventor(s): Qiang Chen, Jonathan Hurtado, Huafang Lai, Haiyan Sun

Keywords(s):

Category(s): Life Science (All LS Techs), Non-Cancer Therapeutics, Pharmaceuticals, Protein/Pharma Production in Plants